Immuneering Corporation Class A (IMRX)
NASDAQ: IMRXHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 7, 4:00 PM ET · Delayed 15 min
IMRX stock chart
Technical analysisKey statistics
All statistics- Market cap
- $249.73M
- EPS (TTM)
- -$0.93
- Dividend yield
- None
- 52-week range
- 3.74 – 8.48
- Day range
- 3.74 – 3.92
- Volume / Avg
- 747.56K / 707.66K
- Beta
- —
- Shares outstanding
- 64.70M
52-week range
IMRX stock today
Immuneering (IMRX) closed at $3.86 on Oct 7, up 0.78% (+$0.03), versus the S&P 500's 0.22% decline. At this level, IMRX sits near the bottom of its 52-week range of $3.74 to $8.48: 54.5% below the high, set on Jan 7, 2026 and 3.2% above the low. IMRX is down 41.3% year to date, underperforming the S&P 500 (+14.0%). Over the past 12 months, the stock has lost 36.8%.
Immuneering has posted a net loss over the last twelve months (EPS of -$0.93), so its P/E ratio is not meaningful.
Summary generated from market data by MetaCap's automated system. Methodology
About Immuneering
Company profile- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- IPO year
- 2021
Immuneering peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| ZNTLZentalis Pharmaceuticals Inc. | 2.55 | -4.49% | $250.21M | vs IMRX |
| LFCRLifecore Biomedical Inc. | 6.44 | -0.15% | $244.11M | vs IMRX |
| VCREVicore Pharma Holding AB ADR | 8.66 | -2.74% | $243.90M | vs IMRX |
| UPBUpstream Bio Inc. | 4.61 | +0.44% | $252.49M | vs IMRX |
| AKBAAkebia Therapeutics Inc. | 0.8734 | -0.58% | $242.02M | vs IMRX |
| AMRNAmarin Corporation plc | 12.02 | -0.41% | $253.90M | vs IMRX |
| CAMPCAMP4 Therapeutics Corporation | 3.84 | -3.03% | $240.97M | vs IMRX |
| PYXSPyxis Oncology Inc. | 2.01 | -0.49% | $240.11M | vs IMRX |
Indexes, lists and sector
Immuneering stock FAQ
What is Immuneering's stock price today?
IMRX last traded at $3.86 as of Oct 7, 4:00 PM EDT, up 0.78% on the day. Prices are delayed at least 15 minutes.
What is the IMRX 52-week high?
The 52-week high for IMRX is $8.48 and the 52-week low is $3.74. The stock is currently 54.5% below its high.